| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 3 |
| 1 | LEVOTHYROXINE SODIUM | 3 |
| 2 | ACETAMINOPHEN | 2 |
| 3 | ALENDRONATE SODIUM | 2 |
| 4 | ATORVASTATIN CALCIUM | 2 |
| 5 | ATORVASTATIN CALCIUM, FILM COATED | 2 |
| 6 | LEVOTHYROXINE SODIUM ANHYDROUS | 2 |
| 7 | LORAZEPAM | 2 |
| 8 | METHOTREXATE | 2 |
| 9 | METHOTREXATE SODIUM | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | AMLODIPINE, VALSARTAN AND HYDROCHLOROTHIAZIDE | 1 | 0.0200 |
| 1 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 1 | 0.0004 |
| 2 | CEVIMELINE HYDROCHLORIDE | 1 | 0.0004 |
| 3 | ETODOLAC | 1 | 0.0002 |
| 4 | PRAZOSIN | 1 | 0.0002 |
| 5 | AGALSIDASE BETA | 1 | 0.0001 |
| 6 | ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE | 1 | 0.0001 |
| 7 | LITHIUM CARBONATE | 1 | 0.0001 |
| 8 | NIRAPARIB | 1 | 0.0000 |
| 9 | ASCORBIC ACID | 1 | 0.0000 |
| # | Drug class | Count |
|---|---|---|
| 0 | Benzodiazepine [EPC] | 3 |
| 1 | Corticosteroid [EPC] | 2 |
| 2 | Folate Analog Metabolic Inhibitor [EPC] | 2 |
| 3 | HMG-CoA Reductase Inhibitor [EPC] | 2 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 2 |
| 5 | Proton Pump Inhibitor [EPC] | 2 |
| 6 | Tumor Necrosis Factor Blocker [EPC] | 2 |
| 7 | Vitamin C [EPC] | 2 |
| 8 | Vitamin D [EPC] | 2 |
| 9 | Aminosalicylate [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] | 1 | 0.0001 |
| 1 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |
| 2 | Interleukin-17A Antagonist [EPC] | 1 | 0.0000 |
| 3 | Cytochrome P450 3A Inhibitor [EPC] | 1 | 0.0000 |
| 4 | Catecholamine [EPC] | 1 | 0.0000 |
| 5 | Purine Antimetabolite [EPC] | 1 | 0.0000 |
| 6 | Aminosalicylate [EPC] | 1 | 0.0000 |
| 7 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Calcium [EPC] | 1 | 0.0000 |
| 9 | Vitamin D [EPC] | 2 | 0.0000 |